Apollo Hospitals Q4 Results 2022: Net profit declined by 42.88% for Q4FY22

Shreya_Anaokar Shreya Anaokar

Last Updated: 9th December 2022 - 07:22 pm

Listen icon

On 25th May 2022, Apollo Hospitals announced its quarterly results for the last quarter of FY2022.

Key Highlights:

Q4FY22:

- The company's revenue from operations rose 23.65% to Rs.354643 lakhs in the quarter under review from Rs.286795 lakhs in the same quarter last fiscal.

- The company's total income rose 23.84% to Rs.357715 lakhs in the quarter under review from Rs.288840 lakhs in the same quarter last fiscal

- Apollo Hospitals reported a net profit of Rs.9701 lakhs from Rs.16989 lakhs in Q4FY21, a decline by 42.88%

FY2022:

- The company's revenue from operations rose 38.85% to Rs.1466264 lakhs in FY22 from Rs.1056001 lakhs in FY21.

- The company's total income rose 38.99% to Rs.1474078 lakhs in FY22 from Rs.1060500 lakhs in FY21

- Apollo Hospitals reported a net profit of Rs.110836 lakhs from Rs.13677 lakhs in Q4FY21, a growth by 710.38%

 

Segment Revenue:

- Healthcare services: The healthcare services segment reported revenue at Rs.187926 Crore with a growth of 21.85% YoY for Q4FY22 and reported revenue at Rs.801319 lakhs for FY2022 with a growth of 59.52% YoY.

- Apollo digital 24x7: Apollo digital segment reported revenue at Rs.47 Crore

- Clinics: Clinics segment reported revenue at Rs.29670 Crore with a growth of 40.94% YoY for Q4FY22 and reported revenue at Rs.130024 lakhs for FY2022 with a growth of 90.71% YoY.

- Others: The other business segments reported revenue at Rs.105 Crore with a degrowth of 2.7% YoY for Q4FY22 and reported revenue at Rs.422 lakhs for FY2022 with a growth of 0.95% YoY.

- Pharmacy distribution: The pharmacy distribution segment reported revenue at Rs.137402 Crore with a growth of 22.91% YoY for Q4FY22 and reported revenue at Rs.536050 lakhs for FY2022 with a growth of 105.6% YoY.

 

The Company declared a final dividend for the year ended March 31. 2022 of Rs.11.75 (235%) per equity share of the face value of Rs.5/- each.

 

 

How do you rate this article?
Characters remaining (1500)

FREE Trading & Demat Account
+91
''
By proceeding, you agree to our T&Cs*
Mobile No. belongs to
hero_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Want to Use 5paisa
Trading App?